Keyphrases
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
100%
Cytoreductive Surgery
92%
Adjuvant Chemotherapy
42%
Colorectal Cancer
40%
Overall Survival
38%
Metastatic Colorectal Cancer (mCRC)
37%
Peritoneal Cancer Index
37%
Colorectal Metastases
32%
Elderly Patients
32%
Breast Cancer Susceptibility Gene 1 (BRCA1)
30%
Pathological Stage
26%
Secondary Cytoreductive Surgery
26%
Oncological Outcomes
25%
BRCA1, BRCA2
25%
Colorectal Peritoneal Metastases
24%
Retrospective Analysis
24%
Disease-free Survival
23%
Lynch Syndrome
23%
Mutation Carriers
22%
Cancer Patients
22%
Intraperitoneal Chemotherapy
21%
T1N0
21%
Tumor Differentiation
21%
Prognostic Marker
21%
Locally Advanced
21%
Advanced Gastric Adenocarcinoma
21%
Lung Metastasis
20%
Confidence Interval
20%
Liver Metastasis
20%
Patient Selection
19%
Young Patients
19%
Tumor
18%
High Risk
17%
Median Overall Survival
16%
Postoperative Outcomes
16%
Preoperative Chemotherapy
16%
Peritoneal Metastasis
15%
Germline BRCA1/2 mutation
15%
National Cancer Database
15%
Carcinoembryonic Antigen Levels
15%
Pathogenic Variants
15%
Ashkenazi Jews
15%
Hazard Ratio
14%
Pancreatic Cancer
14%
Monotherapy
14%
Prognostic Value
14%
Founder mutation
13%
Intraoperative Radiation Therapy
13%
Israel
12%
Pathological Complete Response
12%
Medicine and Dentistry
Cytoreductive Surgery
94%
Hyperthermic Intraperitoneal Chemotherapy
79%
Overall Survival
66%
Malignant Neoplasm
56%
Peritoneum Metastasis
46%
Metastatic Carcinoma
45%
Peritoneum Cancer
42%
Intraperitoneal Chemotherapy
42%
Adjuvant Chemotherapy
40%
Colorectal Cancer
36%
Metastatic Colorectal Cancer
34%
Elderly Patient
32%
Stomach Adenocarcinoma
32%
Neoplasm
30%
Disease
30%
Disease Free Survival
28%
BRCA1
23%
Tumor Differentiation
21%
Colon Cancer
21%
Recurrent Disease
20%
Lung Metastasis
20%
Cancer
19%
Breast Cancer
18%
Hazard Ratio
18%
Pancreas Adenocarcinoma
17%
Preoperative Chemotherapy
17%
Monotherapy
14%
Clinical Trial
14%
Pancreas Cancer
14%
Surgery
14%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
DNA Repair
12%
Gene Mutation
12%
Liver Metastasis
12%
Surgical Margin
12%
Adjuvant Therapy
12%
Oxaliplatin
11%
Gene Repair
10%
Disease Course
10%
Multiple Endocrine Neoplasia Type I
10%
Clinical Stage
10%
Cancer Research
10%
BRCA2
10%
Rectum Carcinoma
10%
Small Intestine Obstruction
10%
Microsatellite Instability
10%
Ras Signaling
10%
Diagnosis
10%
Pancreas Islet Cell Tumor
10%
Obstruction
10%